Trial access to Embase AI – until April 1, 2026

We would like to inform you that trial access to the Embase AI tool has been launched. The platform will be available until April 1, 2026.

What is Embase AI?

Embase AI is an artificial intelligence-based tool that allows you to ask questions in natural language and receive synthetic answers with source citations in seconds, supporting researchers at every stage of their work – from efficiently searching for reliable publications to analyzing results. The solution is based on the Embase database, which contains over 47 million records in the fields of biomedicine, pharmacy, pharmacology, toxicology, pharmacoeconomics, alternative medicine, and biotechnology.

Quick Start Guide to Embase AI

Key features:

• asking questions in natural language
• automatic conversion of questions into search queries
• generating synthetic answers with citations in the text
• ability to ask follow-up questions
• analysis and modification of the generated search strategy
• exporting sessions for further documentation work

Access:

Access to Embase AI is restricted to users with an active Elsevier account who are logged in. To use the tool, you must:

• create an individual Elsevier account: registration link
• log in through your institution.

Detailed instructions on how to set up and use your account are available here.